# Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC)

> **NCT07697599** · PHASE3 · RECRUITING · sponsor: **Regeneron Pharmaceuticals** · enrollment: 1908 (estimated)

## Conditions studied

- Venous Thromboembolism (VTE)

## Interventions

- **DRUG:** REGN7508
- **DRUG:** REGN9933
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07697599
- **Lead sponsor:** Regeneron Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-09-07
- **Primary completion:** 2029-06-25
- **Final completion:** 2029-09-18
- **Target enrollment:** 1908 (ESTIMATED)
- **Last updated:** 2026-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07697599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07697599, "Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07697599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*